Cover Image

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

Several prospective epidemiological studies have shown that there is a clear inverse relationship between serum highdensity lipoprotein-cholesterol (HDL-C) concentrations and risk for coronary heart disease (CHD), even at low-density lipoprotein-cholesterol (LDL-C) levels below 70 mg/dL. However, mo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Constantine E Kosmas (Author), Ian Martinez (Author), Andreas Sourlas (Author), Kyriaki V Bouza (Author), Frederick N Campos (Author), Verenisse Torres (Author), Peter D Montan (Author), Eliscer Guzman (Author)
Format:	Book
Published:	BioExcel Publishing Ltd, 2018-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary genetic disorders affecting high density lipoprotein (HDL)
by: Constantine E Kosmas, et al.
Published: (2018)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020)

Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
by: Constantine E Kosmas, et al.
Published: (2018)

Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
by: Yonghong Luo MD, et al.
Published: (2023)

Therapeutic management of hyperlipoproteinemia (a)
by: Constantine E Kosmas, et al.
Published: (2019)

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023)

New and emerging lipid-modifying drugs to lower LDL cholesterol
by: Constantine E Kosmas, et al.
Published: (2021)

Association of Decreased High-Density Lipoprotein Cholesterol (HDL-C) With Obesity and Risk Estimates for Decreased HDL-C Attributable to Obesity
by: Kaustubh Bora, et al.
Published: (2017)

Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
by: Renan Dal-Fabbro, et al.
Published: (2024)

Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process
by: Marco Munno, et al.
Published: (2024)

Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy
by: Constantine E Kosmas, et al.
Published: (2017)

DIFFERENCES IN LIPOPROTEIN(A) BY RACE, ETHNICITY, AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
by: Ramzi Dudum, MD MPH, et al.
Published: (2023)

Pengaruh Ekstrak Etanol Jamur Lingzhi (Ganoderma Lucidum)Terhadap Kadar Hdl (High Density Lipoprotein)Pada Tikus Dislipidemia
by: Furi, Pritalia Ratra
Published: (2012)

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024)

Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity
by: Kyung-Hyun Cho, et al.
Published: (2021)

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b for cardiovascular risk assessment - What is the right choice?
by: Shrikanth N Hegde
Published: (2020)

HDL-Associated Lipoproteins: Potential Prognostic Biomarkers for Gram-Negative Sepsis
by: Zou G, et al.
Published: (2022)

Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial
by: DuanBin Li, et al.
Published: (2023)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018)

Hubungan Antara Rasio Kadar Kolesterol Total Terhadap High Density Lipoprotein (HDL) Dengan Insidensi Stroke Iskemik Di RSUD Sukoharjo
by: Wicaksono, Aditya Ginanjar, et al.
Published: (2014)

Pengaruh Ekstrak Etanol Rimpang Temulawak (Curcuma Xanthorrhiza Roxb.) Terhadap Kadar Hdl (High Density Lipoprotein) Pada Tikus Putih Hiperlipidemia
by: KARIMA , NIDA AULIYA
Published: (2012)

Role of Triglyceride to High Density Lipoprotein (TG/HDL) Ratio as A Marker of Insulin Resistance in Adults of Central India: A Narrative Review
by: Khalid Khan, et al.
Published: (2024)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020)

Hypertriglyceridemia promotes dysfunctions in high-density lipoprotein increasing the cardiovascular risk
by: Richard Rarison Cavalcante Meneses, et al.
Published: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023)

Hubungan Antara Rasio Kadar Kolesterol Total Terhadap High-Density Lipoprotein (HDL) Dengan Kejadian Penyakit Jantung Koroner Di RSUD Dr. Moewardi
by: Firdiansyah, Muhammad Hafidz, et al.
Published: (2014)

Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
by: Gabriele Mocciaro, et al.
Published: (2023)

LIPOPROTEIN(A) ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE DEVELOPMENT AND PREDICTION IN PRIMARY PREVENTION FROM REAL-WORLD DATA
by: Wenjun Fan, MD, PhD
Published: (2024)

High Density Lipoproteins From Biological Understanding to Clinical Exploitation
Published: (2015)

High Density Lipoproteins From Biological Understanding to Clinical Exploitation /
Published: (2015)

High Density Lipoproteins From Biological Understanding to Clinical Exploitation
Published: (2015)

Low-Density Lipoproteins Oxidation and Endometriosis
by: Grzegorz Polak, et al.
Published: (2013)

Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages
by: Mitsuhisa Koga, et al.
Published: (2020)

Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo
by: Kyung-Hyun Cho, et al.
Published: (2024)

Atherosclerotic Cardiovascular Disease
Published: (2011)

Plasma Lipoprotein(a) Levels and Atherosclerotic Renal Artery Stenosis in Hypertensive Patients
by: Cristiana Catena, et al.
Published: (2015)

Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis
by: Xishao Xie, et al.
Published: (2017)

The Role of High-Density Lipoprotein in COVID-19
by: Guyi Wang, et al.
Published: (2021)

Hubungan Asupan Vitamin E Dan Kolesterol Dengan Kadar High Density Lipoprotein (HDL) Pada Pasien Penyakit Jantung Koroner Di Ruang Rawat Inap RSUD Dr. Moewardi
by: KURNIASARI, Lutfiana Dewi, et al.
Published: (2015)